These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29992679)

  • 21. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
    Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
    Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China.
    Hou Y; Ye X; Wu G; Cheng G; Du X; He J
    Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies.
    Maciá-Martínez MA; de Abajo FJ; Roberts G; Slattery J; Thakrar B; Wisniewski AF
    Drug Saf; 2016 Jan; 39(1):29-43. PubMed ID: 26507885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal detection using change point analysis in postmarket surveillance.
    Xu Z; Kass-Hout T; Anderson-Smits C; Gray G
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):663-8. PubMed ID: 25903221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study.
    Tribouilloy C; Rusinaru D; Maréchaux S; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Ennezat PV; Garban T; Jobic Y
    Circulation; 2012 Dec; 126(24):2852-8. PubMed ID: 23143159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.
    Caster O; Sandberg L; Bergvall T; Watson S; Norén GN
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):1006-1010. PubMed ID: 28653790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure.
    Battini V; Cocco M; Barbieri MA; Powell G; Carnovale C; Clementi E; Bate A; Sessa M
    Drug Saf; 2024 Sep; 47(9):895-907. PubMed ID: 38687463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions.
    Chandler RE
    Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):389-395. PubMed ID: 30556617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
    Fournier A; Zureik M
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
    Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
    Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
    Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
    Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A conceptual approach to the masking effect of measures of disproportionality.
    Maignen F; Hauben M; Hung E; Holle LV; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):208-17. PubMed ID: 24243699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)].
    Nicot P; Frachon I; Hill C
    Presse Med; 2013 Apr; 42(4 Pt 1):411-8. PubMed ID: 23490638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
    Fusaroli M; Salvo F; Begaud B; AlShammari TM; Bate A; Battini V; Brueckner A; Candore G; Carnovale C; Crisafulli S; Cutroneo PM; Dolladille C; Drici MD; Faillie JL; Goldman A; Hauben M; Herdeiro MT; Mahaux O; Manlik K; Montastruc F; Noguchi Y; Norén GN; Noseda R; Onakpoya IJ; Pariente A; Poluzzi E; Salem M; Sartori D; Trinh NTH; Tuccori M; van Hunsel F; van Puijenbroek E; Raschi E; Khouri C
    Drug Saf; 2024 Jun; 47(6):575-584. PubMed ID: 38713346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.
    Avillach P; Salvo F; Thiessard F; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Bégaud B; Moore N; Pariente A;
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):186-94. PubMed ID: 23670805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.
    Khouri C; Revol B; Lepelley M; Mouffak A; Bernardeau C; Salvo F; Pariente A; Roustit M; Cracowski JL
    J Clin Epidemiol; 2021 Nov; 139():191-198. PubMed ID: 34329725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database.
    de Boissieu P; Kanagaratnam L; Abou Taam M; Roux MP; Dramé M; Trenque T
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):989-92. PubMed ID: 24737486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics.
    Bonneterre V; Bicout DJ; de Gaudemaris R
    Saf Health Work; 2012 Jun; 3(2):92-100. PubMed ID: 22993712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case-non-case studies: Principle, methods, bias and interpretation.
    Faillie JL
    Therapie; 2019 Apr; 74(2):225-232. PubMed ID: 30773344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.